1. Home
  2. TEVA vs HRL Comparison

TEVA vs HRL Comparison

Compare TEVA & HRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • HRL
  • Stock Information
  • Founded
  • TEVA 1901
  • HRL 1891
  • Country
  • TEVA Israel
  • HRL United States
  • Employees
  • TEVA N/A
  • HRL N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • HRL Meat/Poultry/Fish
  • Sector
  • TEVA Health Care
  • HRL Consumer Staples
  • Exchange
  • TEVA Nasdaq
  • HRL Nasdaq
  • Market Cap
  • TEVA 19.2B
  • HRL 16.0B
  • IPO Year
  • TEVA N/A
  • HRL N/A
  • Fundamental
  • Price
  • TEVA $17.16
  • HRL $30.24
  • Analyst Decision
  • TEVA Strong Buy
  • HRL Hold
  • Analyst Count
  • TEVA 8
  • HRL 6
  • Target Price
  • TEVA $19.63
  • HRL $32.33
  • AVG Volume (30 Days)
  • TEVA 7.4M
  • HRL 2.2M
  • Earning Date
  • TEVA 11-06-2024
  • HRL 12-04-2024
  • Dividend Yield
  • TEVA N/A
  • HRL 3.76%
  • EPS Growth
  • TEVA N/A
  • HRL N/A
  • EPS
  • TEVA N/A
  • HRL 1.43
  • Revenue
  • TEVA $16,772,000,000.00
  • HRL $11,980,786,000.00
  • Revenue This Year
  • TEVA $4.70
  • HRL N/A
  • Revenue Next Year
  • TEVA $4.47
  • HRL $2.54
  • P/E Ratio
  • TEVA N/A
  • HRL $21.16
  • Revenue Growth
  • TEVA 9.81
  • HRL N/A
  • 52 Week Low
  • TEVA $9.35
  • HRL $28.51
  • 52 Week High
  • TEVA $19.31
  • HRL $36.86
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 44.51
  • HRL 43.70
  • Support Level
  • TEVA $16.15
  • HRL $29.08
  • Resistance Level
  • TEVA $17.16
  • HRL $30.24
  • Average True Range (ATR)
  • TEVA 0.49
  • HRL 0.61
  • MACD
  • TEVA -0.07
  • HRL -0.02
  • Stochastic Oscillator
  • TEVA 30.38
  • HRL 41.70

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and become a branded food company. The firm sells its wares through multiple channels, including US retail (64% of fiscal 2023 sales), US food service (30%), and international (6%). By product, 70% of fiscal 2023 sales were from perishable food and 30% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

Share on Social Networks: